Financial Trends -- 7/10
NTR presents a financially sound commodity producer with improving fundamentals. Revenue stabilized
at $26.9B (+3.5% YoY) after normalizing from the 2022 fertilizer price spike. Adj. EBITDA recovered
strongly to $6.05B (+13% YoY), net income tripled to $2.3B, and gross margins expanded 180bps to
34.5%. FCF recovered to $2.0B (5.5% yield) with disciplined capex below Investor Day targets.
Leverage improved from 2.2x to 1.8x Net Debt/EBITDA. The financial trajectory is clearly improving,
though absolute debt remains elevated at $12B and commodity cyclicality caps the ceiling.
Weight: 25%
FY2025 Revenue
$26.9B
+3.5% YoY | Recovering from 2022 spike
FY2025 Adj. EBITDA
$6.05B
+13% YoY | Approaching FY2023 levels
FY2025 Net Income
$2.30B
3.3x YoY | One-time charges fell away
FY2025 FCF
$2.0B
5.5% yield | +45% YoY recovery
Revenue & Adj. EBITDA (Annual, USD B)
Revenue stabilizing post-fertilizer spike; EBITDA recovering strongly.
Revenue declined from the 2022 fertilizer price spike but stabilized at $26.9B in FY2025 (+3.5% YoY).
Adj. EBITDA recovered to $6.05B (+13% YoY), approaching FY2023 levels despite lower fertilizer prices,
driven by volume growth and cost discipline. Consensus expects continued gradual recovery with revenue
reaching ~$28-29.5B and EBITDA ~$6.4-6.8B by FY2027E.
Revenue recovering from 2022 peak. Gross margin expanded 180bps to 34.5% on mix and cost reductions. Data sourced from Daloopa.
Margin Trends
Margins expanding across the board.
Gross margin expanded from 32.7% to 34.5% (+180bps) reflecting higher-margin volume mix and
cost reductions. Adj. EBITDA margin recovered from 20.6% to 22.5% as operating leverage kicked in.
Net income tripled from $700M to $2.3B as one-time charges fell away. The margin trajectory
confirms operational improvement beyond just fertilizer price recovery.
Gross margin 34.5% is highest in the FY2023-FY2025 window. Data sourced from Daloopa.
Net Income (Annual, USD B)
Net income tripled to $2.3B as one-time charges fell away.
FY2024 net income of $700M was depressed by one-time items and weaker fertilizer pricing.
The strong recovery in FY2025 to $2.3B reflects the combination of higher volumes, cost
discipline, margin expansion, and normalization of non-recurring charges. This demonstrates
the operating leverage inherent in the potash oligopoly model.
Net income recovery driven by volume, cost discipline, and normalization of charges. Data sourced from Daloopa.
Free Cash Flow (Annual, USD B)
FCF recovered to $2.0B (5.5% yield) with disciplined capex.
Cash from operations improved from $3.54B to $4.01B (+13%). CapEx was reduced from $2.67B in
FY2023 to $2.01B in FY2025 -- well below the Investor Day target of $2.2-2.3B. The resulting
$2.0B FCF represents a 5.5% yield on the current $36.3B market cap. Dividends were $1.06B
(52% FCF payout), and ratable buybacks of ~$600M/year demonstrate shareholder return commitment.
The 8th consecutive year of per-share dividend increase ($2.18/share).
FCF yield: FY2023 6.6% | FY2024 3.8% | FY2025 5.5%. Buybacks ~$50M/month (~$600M/year). Data sourced from Daloopa.
Balance Sheet & Leverage
Leverage improved from 2.2x to 1.8x, trending toward 1.5x target.
Total debt was reduced by ~$800M YoY through divestiture proceeds and FCF to $12.0B. Adj. net debt
declined to $11.1B. The 1.8x Net Debt/EBITDA is trending toward management mid-cycle target of
1.5x. BBB investment-grade credit rating maintained. Management targets max 2.5x at trough.
Equity base stable at ~$25B despite ongoing buybacks, reflecting retained earnings growth.
BBB investment-grade rating. Debt reduced ~$800M YoY. Max trough leverage target: 2.5x. Data sourced from Daloopa.
Consensus Estimates vs. Actuals
| Metric | FY2025A | FY2026E | FY2027E |
|---|---|---|---|
| Revenue | $26.9B | ~$28.0B (+4%) | ~$29.5B (+5%) |
| Adj. EBITDA | $6.05B | ~$6.4B (+6%) | ~$6.8B (+6%) |
| Net Income | $2.30B | ~$2.5B (+9%) | ~$2.7B (+8%) |
| FCF | $2.0B | ~$2.2B (+10%) | ~$2.5B (+14%) |
| Net Debt / EBITDA | 1.8x | ~1.6x | ~1.4x |
| Dividend / Share | $2.18 | ~$2.22 (+2%) | ~$2.26 (+2%) |
Consensus expects continued gradual recovery.
Street models mid-single-digit revenue growth as fertilizer volumes normalize and potash pricing
stabilizes. EBITDA growth of ~6% annually implies modest margin expansion. Leverage should
reach the 1.5x mid-cycle target by FY2027E. The outlook is supportive but not aggressive --
consensus is pricing in steady improvement, not a return to the 2022 commodity super-cycle.
Consensus estimates approximate. Based on sell-side median. Data sourced from Daloopa.
Acceleration / Deceleration Analysis
| Signal | Detail | Direction |
|---|---|---|
| Revenue Growth | -10.7% (FY2024) improved to +3.5% (FY2025); post-spike normalization complete | Recovering |
| Gross Margin | 32.7% to 34.5% (+180bps); mix shift and cost reductions driving expansion | Expanding |
| Adj. EBITDA | $5.36B to $6.05B (+13% YoY); approaching FY2023 levels on lower revenue | Accelerating |
| Net Income | $700M to $2.3B (3.3x YoY); one-time charges normalizing, operating leverage | Strong Recovery |
| Free Cash Flow | $1.38B to $2.0B (+45% YoY); 5.5% yield; capex discipline below Investor Day targets | Recovering |
| Leverage | 2.2x to 1.8x Net Debt/EBITDA; ~$800M debt reduction; trending to 1.5x target | Improving |
| Absolute Debt | $12.0B total debt; $11.1B net debt; still elevated vs. equity base | Caution |
| Cash Balance | $701M; modest relative to $12B debt; relies on FCF generation for flexibility | Caution |
Score Derivation
| Component | Assessment | Score |
|---|---|---|
| FCF generation | $2.0B FCF, 5.5% yield; recovered +45% YoY; capex discipline below targets | 8.0 |
| Margin expansion | Gross margin +180bps to 34.5%; EBITDA margin recovering; operating leverage visible | 7.5 |
| Capital return | $2.18/share dividend (8th consecutive increase); ~$600M/year buybacks; 52% FCF payout | 7.5 |
| Revenue trajectory | +3.5% YoY recovery; still below 2022-2023 peak; commodity price dependent | 6.5 |
| Leverage profile | 1.8x improving but $12B absolute debt; BBB rated; trending to 1.5x target | 6.5 |
| Commodity cyclicality | Potash/nitrogen prices volatile; revenue still below peak; limited pricing power | 5.5 |
| Cash cushion | $701M cash vs $12B debt; modest buffer; relies on consistent FCF | 5.5 |
| Final Score | Strong FCF and margins offset by debt and cyclicality | 7/10 |
Data sourced from Daloopa.